NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球液體活檢市場(循環生物標誌物/產品/應用/最終用戶/臨床應用/癌症類型/樣品類型):計劃/資金/主要合同/公司概況/近期發展趨勢(到2027年預測)

Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, & Others), Initiatives, Funding, Major Deals, 35 Company Profiles & Recent Developments-Forecast to 2027

出版商 iGate Research Pvt Ltd 商品編碼 959889
出版日期 內容資訊 英文 472 Pages
訂單完成後即時交付
價格
全球液體活檢市場(循環生物標誌物/產品/應用/最終用戶/臨床應用/癌症類型/樣品類型):計劃/資金/主要合同/公司概況/近期發展趨勢(到2027年預測) Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, & Others), Initiatives, Funding, Major Deals, 35 Company Profiles & Recent Developments-Forecast to 2027
出版日期: 2020年09月10日內容資訊: 英文 472 Pages
簡介

到2027年,全球液體活檢市場預計將達到約82億美元。液體活檢是一種非侵入性技術,使用液體樣本來檢測分子生物標誌物,而無需進行昂貴或侵入性的檢查。

液體活檢優於實體腫瘤活檢的好處,癌症患病率增加,對非侵入性治療的偏好增加,公眾支持液體活檢領域的研究活動預計增加的資金和私人資金以及政府的舉措,將在未來幾年推動液體活檢市場的增長。阻礙液體活檢市場增長的關鍵因素包括臨床實用性挑戰,液體活檢測試的敏感性和特異性不足以及醫療報銷和監管情況不明確。

本報告調查和分析了全球液體活檢市場,並提供了有關市場概況,市場規模和預測,按細分市場分析,按地區/國家進行市場分析,競爭狀況等的系統信息。

第1章執行摘要

第2章COVID-19對全球液體活檢市場的影響

第3章世界液體活檢:市場和預測

第4章世界液體活檢:市場佔有率/預測

  • 按循環生物標記
  • 副產品
  • 按應用
  • 通過臨床應用
  • 按癌症類型
  • 最終用戶
  • 按樣品類型
  • 區域分析
  • 國家分析

第5章全球液體活檢市場與預測:循環生物標誌物

  • 循環腫瘤細胞(CTC)市場與預測
  • 循環腫瘤DNA(ctDNA)市場與預測
  • 無細胞DNA(cfDNA)市場與預測
  • 細胞外囊泡(EV)市場與預測
  • 其他循環生物標誌物市場與預測

第6章全球液體活檢市場與預測:按產品分類

  • 成套工具和消耗品市場與預測
  • 設備市場與預測
  • 服務市場與預測

第7章全球液體活檢市場和預測:按應用

  • 腫瘤應用市場與預測
  • 腫瘤學市場與預測:按癌症類型劃分
    • 肺癌
    • 乳腺癌
    • 大腸癌
    • 前列腺癌
    • 胃腸道癌
    • 白血病
    • 其他
  • 非癌症應用市場與預測

第8章全球液體活檢腫瘤學市場與預測:按臨床應用

  • 治療選擇市場與預測
  • 治療監測市場與預測
  • 早期癌症篩查市場與預測
  • 復發監測市場與預測

第9章全球液體活檢市場和預測:最終用戶

  • 參考實驗室市場與預測
  • 醫院和從業者市場與預測
  • 大學與研究中心市場與預測
  • 其他最終用戶市場和預測

第10章全球液體活檢市場和預測:按樣本類型

  • 血液樣本市場與預測
  • 尿液樣本市場與預測
  • 其他液體樣品市場及預測

第11章全球液體活檢市場與預測:區域分析

  • 北美
  • 亞太地區
  • 歐洲
  • 拉丁美洲
  • 中東/非洲

第12章液體活檢的市場佔有率和預測:區域分析

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 韓國
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 其他亞太地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 中東/非洲
    • 阿聯酋
    • 沙特阿拉伯
    • 埃及
    • 其他中東和非洲
  • 拉丁美洲

第13章液體活檢倡議

第14章液體活檢公司資金詳細信息

第15章公司簡介

  • Personal Genome Diagnostics
  • Guardant Health、Inc.
  • Pathway Genomics
  • RainDance Technologies(Bio-Rad Laboratories、Inc.收購)
  • Cardiff Oncology (Previously Trovagene, Inc.)
  • LungLife AI(原 Cynvenio Biosystems、Inc.)
  • Biocept, Inc.
  • ANGLE plc
  • MDxHealth
  • Biolidics Limited(原 Clearbridge Biomedics Pte Ltd)
  • Exosome Diagnostics、Inc.(Bio-Techne Corporation 收購)
  • Foundation Medicine、Inc.
  • Roche Diagnostics(F. Hoffmann-La Roche AG 的子企業)
  • Genomic Health(現為Exact Sciences Corp 的一部份)
  • Myriad Genetics、Inc.
  • Thermo Fisher Scientific, Inc.
  • QIAGEN NV
  • Bio-Rad Laboratories, Inc.
  • Menarini-Silicon Biosystems
  • GRAIL
  • NeoGenomics、Inc.
  • DiaCarta、Inc.
  • OncoCell MDx(現為Immunis.AI)
  • C2i Genomics
  • Biodesix
  • Freenome
  • Inivata
  • CellMax Life
  • Rarecyte Inc.
  • Saga Diagnostics
  • Thrive Earlier Detection Corp.
  • Lucence Diagnostics Pte Ltd
  • Karius, Inc.
  • Clinical Genomics Technologies Pty Ltd(CG)
  • Elypta

第16章全球液體活檢市場:驅動因素

  • 擴大液體活檢的應用範圍,有望擴大液體活檢的市場
  • 在臨床實踐中促進使用液體活檢的個性化藥物
  • 增加老年人口並增加癌症發病率,以促進液體活檢市場
  • 新型液體活檢產品增加了市場收入
  • 政府用於改善癌症檢測的資金促進了液體活檢市場的增長
  • 越來越多的製造商通過合作來專注於研發,以促進液體活檢市場的增長

第17章全球液體活檢市場:挑戰

  • 限制第三方保險公司的承保範圍以限制液體活檢市場
  • 液體活檢臨床應用的挑戰
  • 關於液體活檢的實驗室發育測試(LDT)的法規不明確
目錄

Title:
Global Liquid Biopsy Market
(by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding, Major Deals, 35 Company Profiles and Recent Developments - Forecast to 2027.

The global liquid biopsy market is expected to reach nearly US$ 8.2 Billion by 2027. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. Liquid biopsy aids in planning the required treatment and also check for treatment effectiveness as well as repeated occurrence of tumor during and after the course of cancer treatment. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization of new lesions, drug & therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.

The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years. Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement & regulation scenario.

Recent Developments

  • In June 2020, NeoGenomics, Inc. announced the launch of three liquid biopsy tests for advanced non-small cell lung cancer, all solid tumor types (pan-cancer), and certain breast cancer cases.
  • In June 2020, Guardant Health presented new data demonstrating that its LUNAR-2 liquid biopsy is a highly sensitive test that can detect early-stage colorectal cancer.
  • In January 2020, Personal Genome Diagnostics Inc. partnered with Eisai Co., Ltd. To develop a comprehensive liquid biopsy biomarker discovery solution for oncology
  • In November 2019, Lucence Diagnostics Pte Ltd, a genomic medicine company based in Singapore, raised US$ 20 Million in Series A funding.
  • In June 2019, Saga Diagnostics, a Lund, Sweden based company raised US$ 4.1 Million in a financing round from Hadean Ventures.
  • In February 2019, MDxHealth SA signed an exclusive distribution agreement with LifeLabs to make SelectMDx, the Company's non-invasive liquid biopsy prostate cancer test, available in Canada
  • In August 2018, Bio-Techne Corporation completed its acquisition of Exosome Diagnostics, Inc.

Global Liquid Biopsy Market & Forecast - by Circulating Biomarker

  • Based on circulating biomarkers, the global liquid biopsy market is being dominated by Circulating Tumor Cells (CTCs).
  • The circulating tumor DNA (ctDNA) is the 2nd largest segment of the liquid biopsy market.
  • The cell free DNA (cfDNA) is the third largest segment of the liquid biopsy market.
  • The extracellular vesicles (Evs) segment is the fastest growing segment during the forecast period.

Global Liquid Biopsy Market & Forecast - by Product

  • The global liquid biopsy market, by product, is being dominated by Kits and Consumables.
  • The instruments segment is likely to witness highest growth in the global liquid biopsy market.
  • The services segment captured least share of the liquid biopsy market.

Global Liquid Biopsy Market & Forecast - by Application

  • The global liquid biopsy market, by application, is being dominated by oncology application.
  • Lung cancer and breast cancer accounts for largest share of the liquid biopsy oncology market.
  • The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.

Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application

  • On the basis of clinical application, the therapy selection segment is expected to account for largest share of the liquid biopsy market throughout the forecasting period.
  • Treatment monitoring captured second highest share of the liquid biopsy market in 2019, being followed by the early cancer screening application.
  • Recurrence monitoring captured least share of the liquid biopsy market.

Global Liquid Biopsy Market & Forecast - by End User

  • In 2019, Reference laboratories captured largest share of the global liquid biopsy market.
  • Hospital and Physician laboratories occupied second highest share of the liquid biopsy market in 2019, being followed by Academic and Research Centers.

Global Liquid Biopsy Market & Forecast - by Sample Type

  • Blood is the most widely used sample type and is expected to remain the largest market during the forecasting period as well.
  • The urine sample segment is anticipated to witness noticeable growth throughout the forecast period.

Liquid Biopsy Market & Forecast - Regional Analysis

  • North America accounted for largest share of the global liquid biopsy market in 2019, followed by Asia Pacific.
  • In North America, United States accounted for largest share of the liquid biopsy market.
  • In Europe, Germany and France are the leading market for liquid biopsy.
  • Asia pacific is likely to be the fastest growing market for liquid biopsy during the forecast period.
  • In Asia Pacific, Japan and China are the leading market for liquid biopsy.
  • Latin America is the fourth largest market for liquid biopsy, being followed by Middle East & Africa.

iGATE RESEARCH, report titled "Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding, Major Deals, 35 Company Profiles and Recent Developments - Forecast to 2027" provides a comprehensive assessment of the fast-evolving, high-growth Global Liquid Biopsy Market.

This 472 Page report with 118 Figures and 7 Tables has been analyzed from 16 viewpoints:

1. Global Liquid Biopsy Market & Forecast (2015 - 2027)

2. Impact of COVID-19 on Global Liquid Biopsy Market

3. Global Liquid Biopsy Market Share & Forecast (2015 - 2027)

4. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2015 - 2027)

5. Global Liquid Biopsy Market & Forecast - by Product (2015 - 2027)

6. Global Liquid Biopsy Market & Forecast - by Application (2015 - 2027)

7. Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types (2015 - 2027)

8. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2015 - 2027)

9. Global Liquid Biopsy Market & Forecast - by End User (2015 - 2027)

10. Global Liquid Biopsy Market & Forecast - by Sample Type (2015 - 2027)

11. Liquid Biopsy Market & Forecast - Regional Analysis (2015 - 2027)

12. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2015 - 2027)

13. Liquid Biopsy Initiatives

14. Liquid Biopsy Companies Financing Details

15. 35 Company Profiles - Recent Developments / Initiatives, Major Deals

16. Global Liquid Biopsy Market - Driving Factors & Challenges

Global Liquid Biopsy Market & Forecast - by Circulating Biomarker

1. Circulating Tumor Cells (CTCs)

2. Circulating Tumor DNA (ctDNA)

3. Cell-Free DNA (cfDNA)

4. Extracellular Vesicles (Evs)

5. Other Circulating Biomarkers

Global Liquid Biopsy Market & Forecast - by Product

1. Kits and Consumables

2. Instruments

3. Services

Global Liquid Biopsy Market & Forecast - by Application

1. Oncology Application

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Gastrointestinal Cancer
  • Leukaemia
  • Others

2. Non-Cancer Application

Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application

1. Therapy Selection

2. Treatment Monitoring

3. Early Cancer Screening

4. Recurrence Monitoring

Global Liquid Biopsy Market & Forecast - by End User

1. Reference Laboratories

2. Hospitals and Physician Laboratories

3. Academic and Research Centers

4. Other End Users

Global Liquid Biopsy Market & Forecast - by Sample Type

1. Blood Sample

2. Urine Sample

3. Other Fluids Sample

Liquid Biopsy Market & Forecast - Regional Analysis

1. North America

  • United States
  • Canada

2. Asia Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific

3. Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Rest of Europe

4. Middle East & Africa

  • UAE
  • Saudi Arabia
  • Egypt
  • Rest of Middle East & Africa

5. Latin America

Liquid Biopsy Market - Company Profiles, Recent Developments / Initiatives, Major Deals

1. Personal Genome Diagnostics

2. Guardant Health, Inc.

3. Pathway Genomics

4. RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)

5. Cardiff Oncology (Previously Trovagene, Inc.)

6. LungLife AI (Formerly Cynvenio Biosystems, Inc.)

7. Biocept, Inc.

8. ANGLE plc

9. MDxHealth

10. Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)

11. Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)

12. Foundation Medicine, Inc

13. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)

14. Genomic Health (Now Part of Exact Sciences Corp)

15. Myriad Genetics, Inc

16. Thermo Fisher Scientific, Inc

17. QIAGEN NV

18. Bio-Rad Laboratories, Inc

19. Menarini-Silicon Biosystems

20. GRAIL

21. NeoGenomics, Inc.

22. DiaCarta, Inc.

23. OncoCell MDx (Now Immunis.AI)

24. C2i Genomics

25. Biodesix

26. Freenome

27. Inivata

28. CellMax Life

29. Rarecyte Inc.

30. Saga Diagnostics

31. Thrive Earlier Detection Corp.

32. Lucence Diagnostics Pte Ltd

33. Karius, Inc.

34. Clinical Genomics Technologies Pty Ltd (CG)

35. Elypta

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Liquid Biopsy Market

3. Global Liquid Biopsy Market & Forecast (2015 - 2027)

4. Global Liquid Biopsy Market Share & Forecast (2015 - 2027)

  • 4.1 Global Liquid Biopsy Market Share & Forecast - by Circulating Biomarker
  • 4.2 Global Liquid Biopsy Market Share & Forecast - by Product
  • 4.3 Global Liquid Biopsy Market Share & Forecast - by Application
  • 4.4 Global Liquid Biopsy Oncology Market Share & Forecast - by Clinical Application
  • 4.5 Global Liquid Biopsy Oncology Market Share & Forecast - By Cancer Types
  • 4.6 Global Liquid Biopsy Market Share & Forecast - by End User
  • 4.7 Global Liquid Biopsy Market Share & Forecast - by Sample Type
  • 4.8 Liquid Biopsy Market Share & Forecast - Regional Analysis
  • 4.9 Liquid Biopsy Market Share & Forecast - Country Wise Analysis

5. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2015 - 2027)

  • 5.1 Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market & Forecast
  • 5.2 Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market & Forecast
  • 5.3 Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market & Forecast
  • 5.4 Global Liquid Biopsy - Extracellular Vesicles (EVs) Market & Forecast
  • 5.5 Global Liquid Biopsy - Other Circulating Biomarkers Market & Forecast

6. Global Liquid Biopsy Market & Forecast - by Product (2015 - 2027)

  • 6.1 Global Liquid Biopsy - Kits and Consumables Market & Forecast
  • 6.2 Global Liquid Biopsy - Instruments Market & Forecast
  • 6.3 Global Liquid Biopsy - Services Market & Forecast

7. Global Liquid Biopsy Market & Forecast - by Application (2015 - 2027)

  • 7.1 Global Liquid Biopsy - Oncology Application Market & Forecast
  • 7.2 Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types
    • 7.2.1 Lung Cancer Liquid Biopsy Market & Forecast
    • 7.2.2 Breast Cancer Liquid Biopsy Market & Forecast
    • 7.2.3 Colorectal Cancer Liquid Biopsy Market & Forecast
    • 7.2.4 Prostate Cancer Liquid Biopsy Market & Forecast
    • 7.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
    • 7.2.6 Leukaemia Liquid Biopsy Market & Forecast
    • 7.2.7 Others Liquid Biopsy Market & Forecast
  • 7.3 Global Liquid Biopsy - Non-Cancer Application Market & Forecast

8. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2015 - 2027)

  • 8.1 Global Liquid Biopsy Oncology Application - Therapy Selection Market & Forecast
  • 8.2 Global Liquid Biopsy Oncology Application - Treatment Monitoring Market & Forecast
  • 8.3 Global Liquid Biopsy Oncology Application - Early Cancer Screening Market & Forecast
  • 8.4 Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market & Forecast

9. Global Liquid Biopsy Market & Forecast - by End User (2015 - 2027)

  • 9.1 Global Liquid Biopsy - Reference Laboratories Market & Forecast
  • 9.2 Global Liquid Biopsy - Hospitals and Physician Laboratories Market & Forecast
  • 9.3 Global Liquid Biopsy - Academic and Research Centers Market & Forecast
  • 9.4 Global Liquid Biopsy - Other End Users Market & Forecast

10. Global Liquid Biopsy Market & Forecast - by Sample Type (2015 - 2027)

  • 10.1 Global Liquid Biopsy - Blood Sample Market & Forecast
  • 10.2 Global Liquid Biopsy - Urine Sample Market & Forecast
  • 10.3 Global Liquid Biopsy - Other Fluids Sample Market & Forecast

11. Liquid Biopsy Market & Forecast - Regional Analysis (2015 - 2027)

  • 11.1 North America Liquid Biopsy Market & Forecast
  • 11.2 Asia Pacific Liquid Biopsy Market & Forecast
  • 11.3 Europe Liquid Biopsy Market & Forecast
  • 11.4 Latin America Liquid Biopsy Market & Forecast
  • 11.5 Middle East & Africa Liquid Biopsy Market & Forecast

12. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2015 - 2027)

  • 12.1 North America Liquid Biopsy Market & Forecast
    • 12.1.1 United States Liquid Biopsy Market & Forecast
    • 12.1.2 Canada Liquid Biopsy Market & Forecast
  • 12.2 Asia Pacific Liquid Biopsy Market & Forecast
    • 12.2.1 South Korea Liquid Biopsy Market & Forecast
    • 12.2.2 Japan Liquid Biopsy Market & Forecast
    • 12.2.3 China Liquid Biopsy Market & Forecast
    • 12.2.4 India Liquid Biopsy Market & Forecast
    • 12.2.5 Australia Liquid Biopsy Market & Forecast
    • 12.2.6 Rest of Asia Pacific Liquid Biopsy Market & Forecast
  • 12.3 Europe Liquid Biopsy Market & Forecast
    • 12.3.1 Germany Liquid Biopsy Market & Forecast
    • 12.3.2 France Liquid Biopsy Market & Forecast
    • 12.3.3 United Kingdom Liquid Biopsy Market & Forecast
    • 12.3.4 Italy Liquid Biopsy Market & Forecast
    • 12.3.5 Spain Liquid Biopsy Market & Forecast
    • 12.3.6 Rest of Europe Liquid Biopsy Market & Forecast
  • 12.4 Middle East & Africa Liquid Biopsy Market & Forecast
    • 12.4.1 UAE Liquid Biopsy Market & Forecast
    • 12.4.2 Saudi Arabia Liquid Biopsy Market & Forecast
    • 12.4.3 Egypt Liquid Biopsy Market & Forecast
    • 12.4.4 Rest of Middle East & Africa Liquid Biopsy Market & Forecast
  • 12.5 Latin America Liquid Biopsy Market & Forecast

13. Liquid Biopsy Initiatives

14. Liquid Biopsy Companies Financing Details

15. Company Profiles

  • 15.1 Personal Genome Diagnostics
    • 15.1.1 Company Overview
    • 15.1.2 Recent Developments / Initiatives
  • 15.2 Guardant Health, Inc.
    • 15.2.1 Company Overview
    • 15.2.2 Recent Developments / Initiatives
  • 15.3 Pathway Genomics
    • 15.3.1 Company Overview
    • 15.3.2 Recent Developments / Initiatives
  • 15.4 RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)
    • 15.4.1 Company Overview
    • 15.4.2 Recent Developments / Initiatives
  • 15.5 Cardiff Oncology (Previously Trovagene, Inc.)
    • 15.5.1 Company Overview
    • 15.5.2 Recent Developments / Initiatives
  • 15.6 LungLife AI (Formerly Cynvenio Biosystems, Inc.)
    • 15.6.1 Company Overview
    • 15.6.2 Recent Developments / Initiatives
  • 15.7 Biocept, Inc.
    • 15.7.1 Company Overview
    • 15.7.2 Recent Developments / Initiatives
  • 15.8 ANGLE plc
    • 15.8.1 Company Overview
    • 15.8.2 Recent Developments / Initiatives
  • 15.9 MDxHealth
    • 15.9.1 Company Overview
    • 15.9.2 Recent Developments / Initiatives
  • 15.10 Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)
    • 15.10.1 Company Overview
    • 15.10.2 Recent Developments / Initiatives
  • 15.11 Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)
    • 15.11.1 Company Overview
    • 15.11.2 Recent Developments / Initiatives
  • 15.12 Foundation Medicine, Inc.
    • 15.12.1 Company Overview
    • 15.12.2 Recent Developments / Initiatives
  • 15.13 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
    • 15.13.1 Company Overview
    • 15.13.2 Recent Developments / Initiatives
  • 15.14 Genomic Health (Now Part of Exact Sciences Corp)
    • 15.14.1 Company Overview
    • 15.14.2 Recent Developments / Initiatives
  • 15.15 Myriad Genetics, Inc.
    • 15.15.1 Company Overview
    • 15.15.2 Recent Developments / Initiatives
  • 15.16 Thermo Fisher Scientific, Inc.
    • 15.16.1 Company Overview
    • 15.16.2 Recent Developments / Initiatives
  • 15.17 QIAGEN NV
    • 15.17.1 Company Overview
    • 15.17.2 Recent Developments / Initiatives
  • 15.18 Bio-Rad Laboratories, Inc.
    • 15.18.1 Company Overview
    • 15.18.2 Recent Developments / Initiatives
  • 15.19 Menarini-Silicon Biosystems
    • 15.19.1 Company Overview
    • 15.19.2 Recent Developments / Initiatives
  • 15.20 GRAIL
    • 15.20.1 Company Overview
    • 15.20.2 Recent Developments / Initiatives
  • 15.21 NeoGenomics, Inc.
    • 15.21.1 Company Overview
    • 15.21.2 Recent Developments / Initiatives
  • 15.22 DiaCarta, Inc.
    • 15.22.1 Company Overview
    • 15.22.2 Recent Developments / Initiatives
  • 15.23 OncoCell MDx (Now Immunis.AI)
    • 15.23.1 Company Overview
    • 15.23.2 Recent Developments / Initiatives
  • 15.24 C2i Genomics
    • 15.24.1 Company Overview
  • 15.25 Biodesix
    • 15.25.1 Company Overview
    • 15.25.2 Recent Developments / Initiatives
  • 15.26 Freenome
    • 15.26.1 Company Overview
    • 15.26.2 Recent Developments / Initiatives
  • 15.27 Inivata
    • 15.27.1 Company Overview
    • 15.27.2 Recent Developments / Initiatives
  • 15.28 CellMax Life
    • 15.28.1 Company Overview
    • 15.28.2 Recent Developments / Initiatives
  • 15.29 Rarecyte Inc.
    • 15.29.1 Company Overview
    • 15.29.2 Recent Developments / Initiatives
  • 15.30 Saga Diagnostics
    • 15.30.1 Company Overview
    • 15.30.2 Recent Developments / Initiatives
  • 15.31 Thrive Earlier Detection Corp.
    • 15.31.1 Company Overview
    • 15.31.2 Recent Developments / Initiatives
  • 15.32 Lucence Diagnostics Pte Ltd
    • 15.32.1 Company Overview
    • 15.32.2 Recent Developments / Initiatives
  • 15.33 Karius, Inc.
    • 15.33.1 Company Overview
    • 15.33.2 Recent Developments / Initiatives
  • 15.34 Clinical Genomics Technologies Pty Ltd (CG)
    • 15.34.1 Company Overview
    • 15.34.2 Recent Developments / Initiatives
  • 15.35 Elypta
    • 15.35.1 Company Overview
    • 15.35.2 Recent Developments / Initiatives

16. Global Liquid Biopsy Market - Driving Factors

  • 16.1 Rising Applications of Liquid Biopsy Expected to Boost Liquid Biopsy Market
  • 16.2 Personalized Medicine to Spur Use of Liquid Biopsy Tests in Clinical Practice
  • 16.3 Rising Aging Population and Cancer Incidences to Drive Liquid Biopsy Market
  • 16.4 New Liquid Biopsy Product Launches to Fuel Market Revenues
  • 16.5 Government Funds for Refining Cancer Detection Drives the Liquid Biopsy Market Growth
  • 16.6 Increasing Focus of Manufacturers on Research & Development Through Collaborations To bolster Growth of Liquid Biopsy Market

17. Global Liquid Biopsy Market - Challenges

  • 17.1 Limitations in Third-Party Payer Coverage to Restrict Liquid Biopsy Market
  • 17.2 Liquid Biopsy Clinical Utility Challenges
  • 17.3 Unclear Regulations on Laboratory Developed Tests (LDT) for Liquid Biopsy

List of Figures:

  • Figure 3-1: Global - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 3-2: Global - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 4-1: By Circulating Biomarker - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Figure 4-2: By Circulating Biomarker - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Figure 4-3: By Product - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Figure 4-4: By Product - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Figure 4-5: By Application - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Figure 4-6: By Application - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Figure 4-7: By Clinical Application - Liquid Biopsy Oncology Market Share (Percent), 2015 - 2019
  • Figure 4-8: By Clinical Application - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2020 - 2027
  • Figure 4-9: By End User - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Figure 4-10: By End User - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Figure 4-11: By Sample Type - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Figure 4-12: By Sample Type - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Figure 5-1: Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market (Million US$), 2015 - 2019
  • Figure 5-2: Global Liquid Biopsy - Forecast for Circulating Tumor Cells (CTCs) Market (Million US$), 2020 - 2027
  • Figure 5-3: Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market (Million US$), 2015 - 2019
  • Figure 5-4: Global Liquid Biopsy - Forecast for Circulating Tumor DNA (ctDNA) Market (Million US$), 2020 - 2027
  • Figure 5-5: Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market (Million US$), 2015 - 2019
  • Figure 5-6: Global Liquid Biopsy - Forecast for Cell-Free DNA (cfDNA) Market (Million US$), 2020 - 2027
  • Figure 5-7: Global Liquid Biopsy - Extracellular Vesicles (Evs) Market (Million US$), 2015 - 2019
  • Figure 5-8: Global Liquid Biopsy - Forecast for Extracellular Vesicles (Evs) Market (Million US$), 2020 - 2027
  • Figure 5-9: Global Liquid Biopsy - Other Circulating Biomarkers Market (Million US$), 2015 - 2019
  • Figure 5-10: Global Liquid Biopsy - Forecast for Other Circulating Biomarkers Market (Million US$), 2020 - 2027
  • Figure 6-1: Global Liquid Biopsy - Kits and Consumables Market (Million US$), 2015 - 2019
  • Figure 6-2: Global Liquid Biopsy - Forecast for Kits and Consumables Market (Million US$), 2020 - 2027
  • Figure 6-3: Global Liquid Biopsy - Instruments Market (Million US$), 2015 - 2019
  • Figure 6-4: Global Liquid Biopsy - Forecast for Instruments Market (Million US$), 2020 - 2027
  • Figure 6-5: Global Liquid Biopsy - Services Market (Million US$), 2015 - 2019
  • Figure 6-6: Global Liquid Biopsy - Forecast for Services Market (Million US$), 2020 - 2027
  • Figure 7-1: Global Liquid Biopsy - Oncology Application Market (Million US$), 2015 - 2019
  • Figure 7-2: Global Liquid Biopsy - Forecast for Oncology Application Market (Million US$), 2020 - 2027
  • Figure 7-3: Global - Lung Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-4: Global - Forecast for Lung Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-5: Global - Breast Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-6: Global - Forecast for Breast Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-7: Global - Colorectal Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-8: Global - Forecast for Colorectal Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-9: Global - Prostate Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-10: Global - Forecast for Prostate Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-11: Global - Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-12: Global - Forecast for Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-13: Global - Leukaemia Cancer Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-14: Global - Forecast for Leukaemia Cancer Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-15: Global - Others Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 7-16: Global - Forecast for Others Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 7-17: Global Liquid Biopsy - Non-Cancer Application Market (Million US$), 2015 - 2019
  • Figure 7-18: Global Liquid Biopsy - Forecast for Non-Cancer Application Market (Million US$), 2020 - 2027
  • Figure 8-1: Global Liquid Biopsy Oncology Application - Therapy Selection Market (Million US$), 2015 - 2019
  • Figure 8-2: Global Liquid Biopsy Oncology Application - Forecast for Therapy Selection Market (Million US$), 2020 - 2027
  • Figure 8-3: Global Liquid Biopsy Oncology Application - Treatment Monitoring Market (Million US$), 2015 - 2019
  • Figure 8-4: Global Liquid Biopsy Oncology Application - Forecast for Treatment Monitoring Market (Million US$), 2020 - 2027
  • Figure 8-5: Global Liquid Biopsy Oncology Application - Early Cancer Screening Market (Million US$), 2015 - 2019
  • Figure 8-6: Global Liquid Biopsy Oncology Application - Forecast for Early Cancer Screening Market (Million US$), 2020 - 2027
  • Figure 8-7: Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market (Million US$), 2015 - 2019
  • Figure 8-8: Global Liquid Biopsy Oncology Application - Forecast for Recurrence Monitoring Market (Million US$), 2020 - 2027
  • Figure 9-1: Global Liquid Biopsy - Reference Laboratories Market (Million US$), 2015 - 2019
  • Figure 9-2: Global Liquid Biopsy - Forecast for Reference Laboratories Market (Million US$), 2020 - 2027
  • Figure 9-3: Global Liquid Biopsy - Hospitals and Physician Laboratories Market (Million US$), 2015 - 2019
  • Figure 9-4: Global Liquid Biopsy - Forecast for Hospitals and Physician Laboratories Market (Million US$), 2020 - 2027
  • Figure 9-5: Global Liquid Biopsy - Academic and Research Centers Market (Million US$), 2015 - 2019
  • Figure 9-6: Global Liquid Biopsy - Forecast for Academic and Research Centers Market (Million US$), 2020 - 2027
  • Figure 9-7: Global Liquid Biopsy - Other End Users Market (Million US$), 2015 - 2019
  • Figure 9-8: Global Liquid Biopsy - Forecast for Other End Users Market (Million US$), 2020 - 2027
  • Figure 10-1: Global Liquid Biopsy - Blood Sample Market (Million US$), 2015 - 2019
  • Figure 10-2: Global Liquid Biopsy - Forecast for Blood Sample Market (Million US$), 2020 - 2027
  • Figure 10-3: Global Liquid Biopsy - Urine Sample Market (Million US$), 2015 - 2019
  • Figure 10-4: Global Liquid Biopsy - Forecast for Urine Sample Market (Million US$), 2020 - 2027
  • Figure 10-5: Global Liquid Biopsy - Other Fluids Sample Market (Million US$), 2015 - 2019
  • Figure 10-6: Global Liquid Biopsy - Forecast for Other Fluids Sample Market (Million US$), 2020 - 2027
  • Figure 11-1: North America - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 11-2: North America - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 11-3: Asia Pacific - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 11-4: Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 11-5: Europe - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 11-6: Europe - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 11-7: Latin America - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 11-8: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 11-9: Middle East & Africa - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 11-10: Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-1: United States - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-2: United States - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-3: Canada - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-4: Canada - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-5: South Korea - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-6: South Korea - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-7: Japan - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-8: Japan - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-9: China - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-10: China - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-11: India - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-12: India - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-13: Australia - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-14: Australia - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-15: Rest of Asia Pacific - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-16: Rest of Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-17: Germany - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-18: Germany - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-19: France - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-20: France - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-21: United Kingdom - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-22: United Kingdom - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-23: Italy - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-24: Italy - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-25: Spain - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-26: Spain - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-27: Rest of Europe - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-28: Rest of Europe - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-29: UAE - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-30: UAE - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-31: Saudi Arabia - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-32: Saudi Arabia - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-33: Egypt - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-34: Egypt - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-35: Rest of Middle East & Africa - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-36: Rest of Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027
  • Figure 12-37: Latin America - Liquid Biopsy Market (Million US$), 2015 - 2019
  • Figure 12-38: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2020 - 2027

List of Tables:

  • Table 4-1: By Cancer Types - Liquid Biopsy Oncology Market Share (Percent), 2015 - 2019
  • Table 4-2: By Cancer Types - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2020 - 2027
  • Table 4-3: By Region - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Table 4-4: By Region - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Table 4-5: By Country - Liquid Biopsy Market Share (Percent), 2015 - 2019
  • Table 4-6: By Country - Forecast for Liquid Biopsy Market Share (Percent), 2020 - 2027
  • Table 15-1: Clearbridge BioMedics - Distributors in EMEA and APAC Regions